Arix Bioscience (LSE:ARIX) YoY EBITDA Growth : -29.41% (As of Jun. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Arix Bioscience YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Arix Bioscience's YoY EBITDA Growth for the quarter that ended in Jun. 2023 was -29.41%.

Arix Bioscience's EBITDA per Share for the six months ended in Jun. 2023 was £-0.02.

Arix Bioscience YoY EBITDA Growth Historical Data

The historical data trend for Arix Bioscience's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arix Bioscience YoY EBITDA Growth Chart

Arix Bioscience Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

YoY EBITDA Growth

Get a 7-Day Free Trial

33.97

13.59

44.94

36.73

-22.58

Arix Bioscience Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
YoY EBITDA Growth	Get a 7-Day Free Trial								35.00	37.93	-30.77	-16.67	-29.41

Arix Bioscience YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Arix Bioscience's YoY EBITDA Growth for the fiscal year that ended in Dec. 2022 is calculated as:

	YoY EBITDA Growth (A: Dec. 2022 )
=	(EBITDA per Share (A: Dec. 2022 )	-	EBITDA per Share (A: Dec. 2021 ))	/	\| EBITDA per Share (A: Dec. 2021 ) \|
=	(-0.038	-	-0.031)	/	\| -0.031 \|
=	-22.58 %

Arix Bioscience's YoY EBITDA Growth for the quarter that ended in Jun. 2023 is calculated as:

	YoY EBITDA Growth (Q: Jun. 2023 )
=	(EBITDA per Share (Q: Jun. 2023 )	-	EBITDA per Share (Q: Jun. 2022 ))	/	\| EBITDA per Share (Q: Jun. 2022 )) \|
=	(-0.022	-	-0.017)	/	\| -0.017 \|
=	-29.41 %

Arix Bioscience YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Arix Bioscience's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Arix Bioscience (LSE:ARIX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arix Bioscience PLC (LSE:ARIX) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

50 Duke Street, Duke Street House, London, GBR, W1K 6JL

Website

https://www.arixbioscience.com

Arix Bioscience PLC is a healthcare and life science company. Its business model is to source, finance, and develop healthcare and life science businesses that deliver or seek to deliver therapies to patients. Its segment includes sourcing, financing, and developing healthcare and life science businesses globally.

Arix Bioscience (LSE:ARIX) Headlines

No Headlines